Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II

Human leukocyte antigen (HLA) molecular mismatch is a powerful biomarker of rejection. Few studies have explored its use in assessing rejection risk in heart transplant recipients. We tested the hypothesis that a combination of HLA Epitope Mismatch Algorithm (HLA-EMMA) and Predicted Indirectly Recog...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellison, M., Mangiola, M., Marrari, M., Bentlejewski, C., Sadowski, J., Zern, D., Kramer, Cynthia Silvia Maria, Heidt, S., Niemann, M., Xu, Q., Dipchand, A. I., Mahle, W. T., Rossano, J. W., Canter, C. E., Singh, T. P., Zuckerman, W. A., Hsu, D. T., Feingold, B., Webber, S. A., Zeevi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043167/
https://www.ncbi.nlm.nih.gov/pubmed/36999035
http://dx.doi.org/10.3389/fimmu.2023.1110292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043167/
https://www.ncbi.nlm.nih.gov/pubmed/36999035
http://dx.doi.org/10.3389/fimmu.2023.1110292

Ejemplares similares